The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...
The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...
The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a ...
A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals ...
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
The US Food and Drug Administration has approved the first-ever non-opioid pain reliever in more than two decades.According ...
Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.
US federal officials have approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The US Food and Drug ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. The new development is ...
The Food and Drug Administration has approved a first of its kind prescription pain medication that is non-opioid.
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...